Tumor Treating Fields Medical Policy Update

Effective for dates of service beginning March 1, 2022, Harvard Pilgrim is updating our commercial medical policy for electric tumor treating field devices to require prior authorization for HCPCS code A4555 (Electrode/transducer for use with electrical stimulation device used for cancer treatment, replacement only). For complete information, including updated coverage criteria for initial and recurrent treatment, please refer to the Tumor Treating Fields Medical Policy.

Publication Information

Audrey Kleinberg,
Director, Provider Relations & Communications

Annmarie Dadoly,

Joseph O’Riordan,

Kristin Edmonston,
Production Coordinator